Global Radioactive Monoclonal Antibody Sales Market Report Forecast 2017-2021

March 2017 | 119 pages | ID: G6AC2632CC9EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

United States
China
Europe
Japan

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Product Segment Analysis:

Type 1
Type 2
Type 3

Application Segment Analysis:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segmentssegments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 RADIOACTIVE MONOCLONAL ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Radioactive Monoclonal Antibody
1.2 Classification of Radioactive Monoclonal Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Radioactive Monoclonal Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Radioactive Monoclonal Antibody Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Radioactive Monoclonal Antibody (2012-2021)
  1.5.1 Global Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Global Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON RADIOACTIVE MONOCLONAL ANTIBODY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Radioactive Monoclonal Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Radioactive Monoclonal Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Radioactive Monoclonal Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL RADIOACTIVE MONOCLONAL ANTIBODY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Radioactive Monoclonal Antibody Market Competition by Manufacturers
  5.1.1 Global Radioactive Monoclonal Antibody Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Radioactive Monoclonal Antibody Revenue and Share by Manufacturers (2012-2017)
5.2 Global Radioactive Monoclonal Antibody (Volume and Value) by Type
  5.5.1 Global Radioactive Monoclonal Antibody Sales and Market Share by Type (2012-2017)
  5.5.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
5.3 Global Radioactive Monoclonal Antibody (Volume and Value) by Regions
  5.3.1 Global Radioactive Monoclonal Antibody Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Radioactive Monoclonal Antibody Revenue and Market Share by Regions (2012-2017)
5.4 Global Radioactive Monoclonal Antibody (Volume) by Application

6 UNITED STATES RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 United States Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  6.1.1 United States Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  6.1.2 United States Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 United States Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
6.2 United States Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
6.3 United States Radioactive Monoclonal Antibody Sales and Market Share by Type
6.4 United States Radioactive Monoclonal Antibody Sales and Market Share by Application

7 CHINA RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 China Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  7.1.1 China Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  7.1.2 China Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 China Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
7.2 China Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
7.3 China Radioactive Monoclonal Antibody Sales and Market Share by Type
7.4 China Radioactive Monoclonal Antibody Sales and Market Share by Application

8 EUROPE RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  8.1.1 Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  8.1.2 Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
8.2 Europe Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
8.3 Europe Radioactive Monoclonal Antibody Sales and Market Share by Type
8.4 Europe Radioactive Monoclonal Antibody Sales and Market Share by Application

9 JAPAN RADIOACTIVE MONOCLONAL ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Radioactive Monoclonal Antibody Sales and Value (2012-2017)
  9.1.1 Japan Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
9.2 Japan Radioactive Monoclonal Antibody Sales and Market Share by Manufacturers
9.3 Japan Radioactive Monoclonal Antibody Sales and Market Share by Type
9.4 Japan Radioactive Monoclonal Antibody Sales and Market Share by Application

10 GLOBAL RADIOACTIVE MONOCLONAL ANTIBODY MANUFACTURERS ANALYSIS

10.1 Pfizer Inc. (USA)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Abbott Laboratories (USA)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Genentech Inc. (USA)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 GlaxoSmithKline Plc (UK)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Immunomedics, Inc. (USA)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Indevus Pharmaceuticals Inc. (USA)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Novartis AG (Switzerland)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 OSI Pharmaceuticals, Inc. (USA)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Paladin Labs Inc. (Canada)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL RADIOACTIVE MONOCLONAL ANTIBODY MARKET FORECAST (2017-2021)

13.1 Global Radioactive Monoclonal Antibody Sales, Revenue Forecast (2017-2021)
13.2 Global Radioactive Monoclonal Antibody Sales Forecast by Regions (2017-2021)
13.3 Global Radioactive Monoclonal Antibody Sales Forecast by Type (2017-2021)
13.4 Global Radioactive Monoclonal Antibody Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Radioactive Monoclonal Antibody
Table Classification of Radioactive Monoclonal Antibody
Figure Global Sales Market Share of Radioactive Monoclonal Antibody by Type in 2015
Table Applications of Radioactive Monoclonal Antibody
Figure Global Sales Market Share of Radioactive Monoclonal Antibody by Application in 2015
Figure United States Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Figure Global Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2021)
Figure Global Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2021)
Table Global Radioactive Monoclonal Antibody Sales of Key Manufacturers (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales Share by Manufacturers (2012-2017)
Figure 2015 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Figure 2016 Radioactive Monoclonal Antibody Sales Share by Manufacturers
Table Global Radioactive Monoclonal Antibody Revenue by Manufacturers (2012-2017)
Table Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table 2016 Global Radioactive Monoclonal Antibody Revenue Share by Manufacturers
Table Global Radioactive Monoclonal Antibody Sales and Market Share by Type (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Type (2012-2017)
Table Global Radioactive Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
Table Global Radioactive Monoclonal Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radioactive Monoclonal Antibody by Type (2012-2017)
Figure Global Radioactive Monoclonal Antibody Revenue Growth Rate by Type (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales and Market Share by Regions (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales Share by Regions (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Regions (2012-2017)
Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Regions (2012-2017)
Table Global Radioactive Monoclonal Antibody Revenue and Market Share by Regions (2012-2017)
Table Global Radioactive Monoclonal Antibody Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Radioactive Monoclonal Antibody by Regions (2012-2017)
Figure Global Radioactive Monoclonal Antibody Revenue Growth Rate by Regions (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales and Market Share by Application (2012-2017)
Table Global Radioactive Monoclonal Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Radioactive Monoclonal Antibody by Application (2012-2017)
Figure Global Radioactive Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure United States Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure United States Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales by Manufacturers (2012-2017)
Table United States Radioactive Monoclonal Antibody Market Share by Manufacturers (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Market Share by Type (2012-2017)
Table United States Radioactive Monoclonal Antibody Sales by Application (2012-2017)
Table United States Radioactive Monoclonal Antibody Market Share by Application (2012-2017)
Figure China Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure China Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure China Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table China Radioactive Monoclonal Antibody Sales by Manufacturers (2012-2017)
Table China Radioactive Monoclonal Antibody Market Share by Manufacturers (2012-2017)
Table China Radioactive Monoclonal Antibody Sales by Type (2012-2017)
Table China Radioactive Monoclonal Antibody Market Share by Type (2012-2017)
Table China Radioactive Monoclonal Antibody Sales by Application (2012-2017)
Table China Radioactive Monoclonal Antibody Market Share by Application (2012-2017)
Figure Europe Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Europe Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Europe Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales by Manufacturers (2012-2017)
Table Europe Radioactive Monoclonal Antibody Market Share by Manufacturers (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Market Share by Type (2012-2017)
Table Europe Radioactive Monoclonal Antibody Sales by Application (2012-2017)
Table Europe Radioactive Monoclonal Antibody Market Share by Application (2012-2017)
Figure Japan Radioactive Monoclonal Antibody Sales and Growth Rate (2012-2017)
Figure Japan Radioactive Monoclonal Antibody Revenue and Growth Rate (2012-2017)
Figure Japan Radioactive Monoclonal Antibody Sales Price Trend (2012-2017)
Table Japan Radioactive Monoclonal Antibody Sales by Manufacturers (2012-2017)
Table Japan Radioactive Monoclonal Antibody Market Share by Manufacturers (2012-2017)
Table Japan Radioactive Monoclonal Antibody Sales by Type (2012-2017)
Table Japan Radioactive Monoclonal Antibody Market Share by Type (2012-2017)
Table Japan Radioactive Monoclonal Antibody Sales by Application (2012-2017)
Table Japan Radioactive Monoclonal Antibody Market Share by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc (UK) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indevus Pharmaceuticals Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OSI Pharmaceuticals, Inc. (USA) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Radioactive Monoclonal Antibody Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radioactive Monoclonal Antibody
Figure Manufacturing Process Analysis of Radioactive Monoclonal Antibody
Figure Radioactive Monoclonal Antibody Industrial Chain Analysis
Table Raw Materials Sources of Radioactive Monoclonal Antibody Major Manufacturers in 2015
Table Major Buyers of Radioactive Monoclonal Antibody
Table Distributors/Traders List
Figure Global Radioactive Monoclonal Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Global Radioactive Monoclonal Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Global Radioactive Monoclonal Antibody Sales Forecast by Regions (2017-2021)
Table Global Radioactive Monoclonal Antibody Sales Forecast by Type (2017-2021)
Table Global Radioactive Monoclonal Antibody Sales Forecast by Application (2017-2021)